hero image hero image

Patients and caregivers can apply FILSUVEZ to all appropriate dystrophic or junctional epidermolysis bullosa wounds, at every dressing change, from the comfort of their own home1

  • Applying FILSUVEZ
  • Usage information
Applying FILSUVEZ

FILSUVEZ puts patients in control of their wound care with at-home application that integrates into existing EB wound care routines1

clinic-visits
No clinic visits or healthcare providers are needed for routine application1

FILSUVEZ is applied in 3 steps1

STEP 1
  • Clean all wounds
  • Using clean or gloved hands, open a new, single-use tube of FILSUVEZ
  • Immediately after opening, apply 1 mm of FILSUVEZ evenly to each nonadhesive wound dressing, or directly to the wound. Once the tube has been opened and applied, discard the tube and any remaining gel
video placeholder
STEP 2
  • Spread the 1 mm layer of FILSUVEZ across the entire wound surface to about the thickness of a credit card
  • If applying to a dressing, spread FILSUVEZ across the entire dressing
video placeholder
STEP 3
  • Cover all wounds with sterile, nonadhesive wound dressings
  • Reapply FILSUVEZ with each dressing change until all wounds are fully healed
  • The tube of FILSUVEZ should only be used once
video placeholder
Watch a wound care-certified nurse from the specialty pharmacy demonstrate proper FILSUVEZ application
video-full-width
Usage information
What to know about prescribing FILSUVEZ to patients with DEB or JEB
FILSUVEZ is supplied in easy-to-use, sterile, single-use tubes1
FILsuvez_Dressing_Change

FILSUVEZ is available through PANTHERx, the specialty pharmacy

credit-card

When applying FILSUVEZ directly to your wounds, a 
1 mm layer (about the thickness of a credit card) should be applied evenly across the entire wound surface

FILsuvez_Dressing_Change

One tube covers the same area as a business envelope

Using FILSUVEZ1
FILsuvez_Dressing_Change

The tube of FILSUVEZ should only be used once. Once the tube has been opened, apply the gel to wounds immediately and then discard the tube and any remaining gel

FILsuvez_Dressing_Change

FILSUVEZ should be stored at room temperature between 68°F and 77°F (20°C to 25°C). Do not freeze

FILsuvez_Dressing_Change

Do not use FILSUVEZ in or around the eyes or mucous membranes (mouth, vagina, or anus). If accidental contact does occur, immediately wash the area with clean water and contact your doctor if you have any discomfort

Access tools and information to assist with prescribing FILSUVEZ
FILSUVEZ Support

Important Safety Information & Indication

Important Safety Information

Warnings & Precautions

Local hypersensitivity and skin reactions have been reported in patients treated with FILSUVEZ, including urticaria and dermatitis. If signs or symptoms of hypersensitivity occur, discontinue use immediately and initiate appropriate therapy.

Adverse Reactions

The most commonly reported adverse reaction in clinical trials was pruritus and pain at the wound application site (7.3%).

Patient Counseling Information

Please refer to Prescribing Information for administration instructions.

To report SUSPECTED ADVERSE REACTIONS, contact Chiesi USA Inc. at 1-888-661-9260 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see Full Prescribing Information.

Indication

FILSUVEZ is indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older.

Important Safety Information & Indication

Important Safety Information

Warnings & Precautions

Local hypersensitivity and skin reactions have been reported in patients treated with FILSUVEZ, including urticaria and dermatitis. If signs or symptoms of hypersensitivity occur, discontinue use immediately and initiate appropriate therapy.

Adverse Reactions

The most commonly reported adverse reaction in clinical trials was pruritus and pain at the wound application site (7.3%).

Patient Counseling Information

Please refer to Prescribing Information for administration instructions.

To report SUSPECTED ADVERSE REACTIONS, contact Chiesi USA Inc. at 1-888-661-9260 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see Full Prescribing Information.

Indication

FILSUVEZ is indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older.
Reference:
1. FILSUVEZ (birch triterpenes) topical gel [prescribing information]. Chiesi USA; 2024.

PP-RA-01347 V1.0